PROTECT

Protect Logo PROTECT is an international cardiology study looking at Dobermanns affected by dilated cardiomyopathy (DCM), a disease of the heart muscle. Vetmedin has been shown to have significant benefits in the treatment of DCM once clinical signs develop. This study will investigate the benefit of medicating Dobermanns with asymptomatic DCM to identify whether this medication will increase the time taken for clinical signs to develop, and also prolong overall life expectancy.

 What is a clinical study?

 What is 'PROTECT'?

 Can my dog take part in PROTECT?

If you have a Dobermann that:

a)is aged 5 to 9 years (inclusive)
b)is not suffering from any other significant disease
c)has never been diagnosed with heart disease
d)isn't pregnant or lactating

He/she may be eligible to take part in the screening part of the trial. Call 01344 742574 for more details.

 What kind of commitment will I need to make?

 How do I find out more?

Log in

For the latest news, research, videos, practice resources and much more, please log in:

Surname: (or email if you have recently registered for the Norman competition)

Practice Postcode:

(PROTECT) Pimobendan Randomized Occult DCM Trial to Evaluate Clinical symptoms & Time to heart failure is a clinical trial investigating the benefit of administering Vetmedin to Dobermanns with pre-clinical DCM. Please log in to find out how you can become involved with the PROTECT study.